Skip to main content

Table 2 Antifungal treatment strategies

From: Analysis of cerebrospinal fluid protein concentrations of patients with cryptococcal meningitis treated with antifungal agents

Antifungal strategies PR-group (n = 28) GR-group (n = 18) P-value
AMB 1(3.57 %) 1(5.56 %) 1.00
AMB+ flucytosine 5(17.9 %) 5(27.8 %) 0.73
AMB+ fluconazole 5(17.9 %) 2(11.1 %) 0.70
AMB+ fluconazole + flucytosine 13(46.2 %) 7(38.9 %) 0.79
AMB+ voriconazole 0(0.00 %) 1(5.56 %) 0.44
Fluconazole 3(10.7 %) 0(0.00 %) 0.29
Fluconazole + flucytosine 0(0.00 %) 2(11.1 %) 0.17
Voriconazole 1(3.57 %) 0(0.00 %) 0.62